Champions oncology, inc. (CSBR)
CashFlow / Yearly
Apr'19Apr'18Apr'17Apr'16Apr'15Apr'14Apr'13Apr'12Apr'11
Operating activities:
Net income

128

-1,476

-6,884

-10,445

-13,139

-7,406

-6,330

-8,661

-3,802

Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation

636

1,004

2,662

2,599

3,162

2,807

2,376

3,323

3,133

Change in fair value of warrant liability

-

-

-

-

981

-965

-74

417

-36

Modification of warrant liability

-

-

-

-

586

0

-

-

-

Gain/loss on sales of assets

-

-

-

-

-5

0

-

-

-

Deferred rent

-397

-454

0

-

-

-

-

-

-

Deferred compensation

0

7

0

-

-

-

-

-

-

Provision for (recovery of) doubtful accounts

71

-44

24

30

0

-

-

-

-

Issuance of common stock for services

6

30

44

44

-

-

-

-

-

Net foreign currency remeasurement loss

-

-

-

-

-

-124

0

-

-

Depreciation and amortization expense

606

360

168

156

214

213

203

-

-

Income tax (benefit) expense

-

-

-

-

-

-

-

-2

-

Income tax (benefit) expense

-

-

-

-

-

-

-

-

11

Depreciation expense

-

-

-

-

-

-

-

105

42

Gain on disposal of equipment

-

-

-

-

-

-

-

-

-1

Changes in operating assets and liabilities:
Accounts receivable

531

1,600

986

282

-265

825

-84

-

-

Grant receivable

-

-

-

-

-

-

0

517

517

Prepaid expenses and other current assets

21

-13

-143

97

-37

68

110

-

-

Restricted cash

-

-

-

-13

-2

-27

42

-150

-

Accounts receivable

-

-

-

-

-

-

-

-1

493

Prepaid expenses, deposits and other

-

-

-

-

-

-

-

-71

-217

Restricted cash

-

-

-

-

-

-

-

-

0

Other long term assets

12

9

107

0

-

-

-

-

-

Accounts payable

653

301

-43

482

433

-223

-472

96

636

Accrued liabilities

611

-90

412

-102

-231

-24

-14

323

62

Other non-current liability

0

30

-44

65

100

0

-

-

-

Deferred revenue

-682

-206

1,771

1,130

-82

977

-71

-433

697

Other liabilities

-

-

-

-

-

-

-

-

-77

Net cash provided by operating activities

1,862

-1,226

-2,840

-6,408

-9,630

-

-

-5,227

-54

Investing activities:
Net cash used in operating activities

-

-

-

-

-

-3,433

-4,302

-

-

Purchase of property and equipment

834

1,229

766

322

119

234

57

519

85

Gain on disposal of fixed assets

0

3

0

-

5

0

-

-

-

Proceeds form sale of property and equipment

-

-

-

-

-

-

-

-

1

Net cash used in investing activities

-834

-1,226

-766

-322

-114

-

-

-519

-84

Financing activities:
Proceeds from exercise of options and warrants

1,465

38

-

-

2

21

0

-

-

Proceeds from June 2016 Public Offering, net of financing costs of $742

-

-

4,340

0

0

-

-

-

-

Proceeds from exercise of options and warrants

-

-

0

-

-

-

-

-

-

Private placement financing, net of financing costs of $880k

-

-

-

-

11,220

0

9,141

-

-

Net cash used in investing activities

-

-

-

-

-

-234

-57

-

-

Proceeds from Executive Note financing

-

-

-

-

2,000

0

-

-

-

Payment of issuance costs related to March 2015 Private Placement

-

-

-

18

0

-

-

-

-

Finance lease payments

262

25

24

24

12

0

-

-

-

Private placement of commons shares and warrants.

-

-

-

-

-

-

-

0

9,095

Purchase of treasury stock

-

-

-

-

-

-

-

-

1,033

Proceeds from exercise of options and warrants

-

-

-

-

-

-

-

97

21

Net cash provided by financing activities

1,203

13

4,316

-42

13,210

-

-

97

8,083

Increase in cash

2,231

-2,439

-

-

-

-

-

-

-

Non-cash investing activities:
Net cash (used in)/provided by financing activities

-

-

-

-

-

21

9,141

-

-

Exchange rate effect on cash and cash equivalents

-

-

-

-

-

-24

25

-54

-60

(Decrease)/Increase in cash and cash equivalents.

-

-

710

-6,772

3,466

-3,670

4,807

-5,703

7,885

Purchase equipment under finance lease

235

0

-

-

124

0

-

-

-

Conversion of executive note financing

-

-

-

-

2,000

0

-

-

-

Reclassification of warrant liability to equity

-

-

-

-

1,616

0

-

-

-